Dion Gisele
- SEC CIK
- 0001873088
No open-market purchases or sales filed in the past year.
Current role at each company
- IKT Inhibikase Therapeutics, Inc.Directoras of Jul 18, 2024
- CTKB Cytek Biosciences, Inc.Directoras of Jun 16, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dion Gisele as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CTKB Cytek Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 (view filing) | Jul 22 | 5 daysLate | Dion GiseleDirector | PPurchase | +5.00K | $17.00 | +$85.0K | New position5.00K after |